Background: Asthma and morbid obesity are common chronic conditions that ma
y be related. Laparoscopic banding provides effective weight control of mor
bid obesity. The aim of this study was to evaluate the prevalence of asthma
in the morbidly obese and the changes in asthma after laparoscopic adjusta
ble gastric banding (LAGB) (Lap-Band(R)) surgery for morbid obesity.
Methods: Asthma was assessed preoperatively in all patients presenting for
LAGB. 32 consecutive asthmatic patients were followed up clinically and by
a standard questionnaire at least 12 months after surgery, and any change i
n asthma impact was recorded.
Results: The prevalence of the doctors' diagnosis of asthma was 24.6% (73 o
f 296 consecutive patients). This was significantly higher than the prevale
nce in the Australian community of 12% to 13% (P < 0.001).
The 32 patients who were followed up had a mean body weight of 125.2 kg and
a body mass index (BMI) of 45.7 kg/m(2) prior to operation, and a weight o
f 89.3 kg (BMI 32.9 kg/m2) at follow-up. All 32 patients recorded a lower a
sthma score postoperatively. There were significant improvements in all asp
ects of asthma assessed. These included severity, daily impact, medications
needed, hospitalization, sleep, and exercise. The mean preoperative scaled
asthma score was 44.5 +/- 16. There was a highly significant reduction at
follow-up to a mean value of 14.3 +/- 11 (P < 0.001).
Conclusions: There is a high prevalence of asthma in morbidly obese adults,
and major reductions in asthma severity occur after Lap-Band(r) surgery an
d weight loss. Mechanisms other than direct weight loss appear to play a pa
rt in this improvement. Prevention of gastroesophageal reflux may be an imp
ortant factor.